SKI Market

A+| A| A-|

Indian Indices

Sensex

76,034.42 -829.29
( -1.08%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

54,230.47 -794.90
(-1.44%)

Nikkei 225

10,315.38 -96.86
(-0.93%)

Forex

USD-INR

91.90 -0.24
(-0.26%)

EUR-INR

106.87 0.29
(0.27%)

GBP-INR

123.51 0.42
(0.34%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

59.74

6601.86

EPS(TTM)

Face Value()

Div & Yield %

5.65

0.15

Back

Bata India consolidated net profit declines 73.26% in the September 2025 quarter

Oct 28,2025

Net profit of Bata India declined 73.26% to Rs 13.90 crore in the quarter ended September 2025 as against Rs 51.98 crore during the previous quarter ended September 2024. Sales declined 4.28% to Rs 801.33 crore in the quarter ended September 2025 as against Rs 837.14 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	801.33	837.14	-4
OPM %	18.09	20.79	-
PBDT	132.54	159.99	-17
PBT	27.56	69.78	-61
NP	13.90	51.98	-73

76,034.42 -829.29 ( -1.08%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

54,230.47 -794.90 (-1.44%)

10,315.38 -96.86 (-0.93%)

91.90 -0.24 (-0.26%)

106.87 0.29 (0.27%)

123.51 0.42 (0.34%)

0.58 0.00 (0.09%)